Large-scale testing (Phase 3)Study completedNCT00364546
What this trial is testing
Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain
Who this might be right for
OsteoarthritisPain Intensity AssessmentArthralgia+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 877